GLP1R and type 2 diabetes mellitus: To ensure statistical power, the GLP‐1 RA trials enrolled T2D patients with longer diabetes duration and higher levels of glycemic dysregulation; mean baseline HbA1c ranged from 55 mmol/mol (7.2%) to 74 mmol/mol (8.7%).4, 5, 6, 7, 8, 9, 10